Extracellular Volume Estimation in the Assessment of Myocardial Viability in Ischaemic Cardiomyopathy
暂无分享,去创建一个
[1] G. Beller,et al. Myocardial viability. Assessment by cardiac scintigraphy. , 1994, Cardiology clinics.
[2] Lippincott Williams Wilkins,et al. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. , 1983, Circulation.
[3] G. Stone,et al. Myocardial viability and CABG surgery: a Bayesian appraisal of STICH , 2019, Nature Reviews Cardiology.
[4] R. Kim,et al. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is “alive” is not enough , 2004, Heart.
[5] P. Ganz,et al. Hypertension and Left Ventricular Hypertrophy Are Associated With Impaired Endothelium‐Mediated Relaxation in Human Coronary Resistance Vessels , 1993, Circulation.
[6] M. Nacif,et al. Practical Implications of Myocardial Viability Studies , 2018, Arquivos brasileiros de cardiologia.
[7] B. Chow,et al. 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial , 2010, Journal of Nuclear Medicine.
[8] André Lamy,et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.
[9] N. Frangogiannis. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure. , 2019, Circulation research.
[10] M. Cheitlin,et al. Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy , 2011 .
[11] S. Bergmann,et al. Assessment of myocardial viability. , 2005, Seminars in nuclear medicine.
[12] R. Gropler,et al. Myocardial viability--what is the definition? , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] D. Baker,et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. , 1994, JAMA.
[14] K. Nakajima,et al. Myocardial viability assessment using nuclear imaging , 2003, Annals of nuclear medicine.
[15] Andrew S Flett,et al. Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.
[16] Patricia A Pellikka,et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[17] E. Nagel,et al. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.
[18] B. Brent,et al. Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.
[19] C. O'connor,et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. , 2007, The Journal of thoracic and cardiovascular surgery.
[20] M. Motwani,et al. Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI , 2017, JACC. Cardiovascular imaging.